Insulin Sensitivity/Resistance Clinical Trials

8 recruiting

Insulin Sensitivity/Resistance Trials at a Glance

8 actively recruiting trials for insulin sensitivity/resistance are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Aarau, Aurora, and Birmingham. Lead sponsors running insulin sensitivity/resistance studies include Finis Terrae University, Institut de Recherches Cliniques de Montreal, and ETH Zurich.

Browse insulin sensitivity/resistance trials by phase

Treatments under study

About Insulin Sensitivity/Resistance Clinical Trials

Looking for clinical trials for Insulin Sensitivity/Resistance? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Insulin Sensitivity/Resistance trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Insulin Sensitivity/Resistance clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

High Intensity Interval Training and Insulin Sensitivity in Type 2 Diabetes

Insulin Sensitivity/ResistanceType 2 DiabetesLifestyle-related Condition
Finis Terrae University36 enrolled1 locationNCT06688461
Recruiting
Not Applicable

Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids

Insulin Sensitivity/ResistanceInflammationType 2 Diabetes+1 more
Institut de Recherches Cliniques de Montreal48 enrolled1 locationNCT04485871
Recruiting
Not Applicable

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

Insulin Sensitivity/ResistanceObesityInsulin Resistance+14 more
Pichamol Jirapinyo, MD, MPH132 enrolled2 locationsNCT06138821
Recruiting
Phase 2

NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals

Diabetes MellitusInsulin Sensitivity/ResistanceCardiovascular Diseases+4 more
University of Alabama at Birmingham200 enrolled1 locationNCT04055428
Recruiting

Puberty Suppression and Cardiometabolic Health

Insulin Sensitivity/ResistanceEndothelial DysfunctionVascular Stiffness+1 more
University of Colorado, Denver30 enrolled1 locationNCT04482374
Recruiting

Response to Semaglutide in Non-diabetic Obese Patients With Varying Degrees of Insulin Resistance

Insulin Sensitivity/ResistanceObesity and OverweightObesity and Obesity-related Medical Conditions+1 more
ETH Zurich40 enrolled1 locationNCT06856291
Recruiting

Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

Diabetes MellitusInsulin Sensitivity/ResistanceObesity+16 more
Osaka Metropolitan University2,000 enrolled1 locationNCT06694012
Recruiting
Not Applicable

Insulin Sensitivity After Breast Cancer

Breast CancerInsulin Sensitivity/ResistanceSurvivorship+1 more
University of Copenhagen24 enrolled1 locationNCT05010356